Randy Joe Maddux - 07 Dec 2021 Form 4 Insider Report for iBio, Inc. (IBIO)

Reporting relationship: Chief Operating Officer
Issuer ticker: IBIO
Reported as of: 07 Dec 2021
Net transaction value: -$25,444
SEC form: 4
Accepted by SEC: 14 Mar 2022, 16:11:30 UTC
Prior SEC filing: 25 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Randy Joe Maddux

Key filing fact

Randy Joe Maddux filed Form 4 for iBio, Inc. (IBIO) on 14 Mar 2022.

Key facts

This page summarizes Randy Joe Maddux's Form 4 filing for iBio, Inc. (IBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Mar 2022, 16:11.

Change

Previous filing in this sequence was filed on 25 Aug 2021.
Current net transaction value: -$25,444.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBIO transaction

Common Stock

Sale

Transaction value: $25,444
Shares: -37,243
Change %: -12%
Price: $0.6832
Shares after: 271,757
Date: 07 Dec 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc.

Footnote F2

These shares were sold in a single transaction at a price of $0.6832 per share.